Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer. [electronic resource]
Producer: 20100225Description: 1378-89 p. digitalISSN:- 1097-0215
- Antineoplastic Agents -- pharmacology
- Azacitidine -- pharmacology
- Base Sequence
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cisplatin -- pharmacology
- DNA Methylation
- Drug Resistance, Neoplasm -- genetics
- Epithelial Cells -- pathology
- Female
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- Membrane Transport Proteins -- genetics
- Molecular Sequence Data
- Myelin Proteins -- genetics
- Myelin and Lymphocyte-Associated Proteolipid Proteins
- Oligonucleotide Array Sequence Analysis
- Ovarian Neoplasms -- drug therapy
- Promoter Regions, Genetic -- genetics
- Proteolipids -- genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Sequence Analysis, DNA -- methods
- Survivors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.